Follow Us
-
+1 700 888 1234
-
Effingerstrasse 40 3008 Bern Switzerland
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Being well aware of the importance of continuing generating evidence that will benefit the overall lung cancer community and the patient advocacy groups in particular, LuCE aims to produce reports and position papers by following a consistent methodology based on:
This is an annual initiative led by Lung Cancer Europe, designed to raise awareness of the real-world challenges faced by people affected by lung cancer across Europe.
The 10th Report, titled “Mental Health and Lung Cancer”, is the largest global survey to date on the psychological and emotional impact of the disease.
Based on data from 2,204 participants across 31 countries, the report highlights the distress, fear, and isolation that often go unrecognised in cancer care – and how many people are left without the mental health support they need.
The survey was conducted online between 28 May and 6 July 2025, and included people living with lung cancer and their caregivers.
The goal of this report is to better understand the emotional and psychological needs of those affected, and to provide clear, practical recommendations for integrating mental health into cancer care.
Download full report below
18 October 2025
In 2024, we at Lung Cancer Europe (LuCE) strengthened our voice and impact across Europe.
We launched our 9th LuCE Report, gathering insights from over 2,000 patients and caregivers in 34 countries.
We introduced the first Access to Treatment Atlas, mapping lung cancer treatment availability across 30 countries.
We expanded our community with new member organisations and brought together representatives from 18 countries at our Members’ Meeting in Madrid.
We also advanced our role in EU policy and scientific leadership, ensuring patient perspectives are embedded in innovation areas such as AI, biomarkers, gene therapy, and lung cancer screening.
Read more below.
September 2025
For the first time in history, lung cancer has been formally included in a global resolution by the World Health Organization (WHO). As the World Health Assembly convenes this week in Geneva to vote on the resolution, Lung Cancer Europe (LuCE) has released a public position statement welcoming this significant development—while urging that it must be followed by immediate and meaningful action.
May 2025
This 9th report titled `Empowering voices: Knowledge and decision-making among people impacted by lung cancer in Europe´ is a descriptive research analysis that explores the level of information, knowledge and decision-making involvement among those impacted by lung cancer in Europe.
November 2024
This report titled `Financial impact of lung cancer: A European Perspective´, is a descriptive research analysis that explores the economic burden of lung cancer, as reported by people diagnosed with the disease and those in a caregiving capacity.
November 2023
The aim of this report is to identify barriers and areas of improvement
to enhance the lung cancer care pathway. Even with differences in the
structure and delivery of care across Europe, the findings of this
report stress the need for person-centred models that develops and
improves partnerships between individuals and their healthcare
providers. It also highlights the continual need for improvement in both
the access and delivery of care for people impacted by lung cancer.
November 2022
This is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness regarding the main challenges faced by people impacted by this disease across Europe.
November 2021
Lung cancer is the biggest cancer killer worldwide. In Europe, there are 470,000 new diagnoses and more than 380,000 lung cancer deaths every year1.
November 2020
This 2020 LuCE Position Paper covers data regarding access to lung cancer treatment and diagnosis, in order to raise awareness about access inequities among patients in European countries.
February 2020
This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face.
November 2019
Welcome to the 3rd edition of the LuCE Report. This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face.
November 2018
After the 1st LuCE Report in 2016, in which we highlighted the main challenges in lung cancer in Europe from the patient perspective, we launch this 2nd Report to deepen our research on one of our main worries: disparities on access across Europe.
November 2017
Thousands of people are diagnosed with lung cancer in Europe every year and sadly this is the biggest cancer killer. Lung cancer is one of the major public health problems today and it requires a global solution.
November 2016
With an estimated incidence of over 449 000 cases per year, lung cancer is one of the most common
malignancies in Europe.
October 2015
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
